Electrolyte Collapse in Advanced CKD: An Advanced Interactive Case

Level: Advanced — nephrology trainee or nephrologist
Topic: Acute electrolyte emergencies in CKD
Educational disclaimer: This case is for postgraduate education only. It does not replace clinical judgment, local monitored-care protocols, specialist consultation, or current prescribing information. Treatment choices and doses must be individualized to the patient, available monitoring, and institutional policy.

Learning objectives

By the end of this case, learners should be able to recognize and prioritize immediately life-threatening hyperkalemia; classify hypotonic hyponatremia when diuretic therapy confounds urine indices; distinguish correction goals from correction ceilings; identify and respond to emerging overcorrection; and integrate acute medication review with a plan for safe reintroduction of disease-modifying CKD and heart-failure therapy.

Clinical scenario

A 68-year-old man with CKD G4 (baseline serum creatinine 2.8 mg/dL), heart failure with reduced ejection fraction, type 2 diabetes, and hypertension is brought to the emergency department because of progressive weakness and confusion. He has had poor oral intake and profuse diarrhea for three days. His medications include lisinopril, spironolactone, and furosemide. He reports no potassium supplements or salt substitute use.

On examination, he is confused but arousable. Blood pressure is 92/58 mmHg, heart rate 110 beats/minute, respiratory rate 22 breaths/minute, and temperature 37.2 °C. He has dry mucous membranes, cool extremities, no pulmonary crackles, and no peripheral edema. A 12-lead ECG shows tall peaked T waves and QRS widening.

Initial tests show serum sodium 118 mmol/L, potassium 6.8 mmol/L, bicarbonate 12 mmol/L, blood urea nitrogen 98 mg/dL, serum creatinine 4.2 mg/dL, glucose 110 mg/dL, magnesium 1.4 mg/dL, phosphate 5.8 mg/dL, and arterial blood gas pH 7.22 with PaCO₂ 28 mmHg. The patient is oliguric.

Decision point: What must be addressed first, and why? Consider which abnormality has the most immediate risk of sudden death and which treatments only stabilize, shift, or remove potassium.

Stage 1 — First-hour priorities: electrical instability before biochemical elegance

The combination of potassium 6.8 mmol/L, QRS widening, and peaked T waves represents an immediate monitored-care emergency. The initial priority is continuous cardiac monitoring, urgent senior and renal/critical-care involvement, and treatment according to the institution’s severe-hyperkalemia protocol. Intravenous calcium is used to stabilize the myocardium in the presence of ECG changes; it does not remove potassium. Insulin–glucose and adjunctive beta-agonist therapy can shift potassium intracellularly, while repeat potassium and glucose measurements are necessary to identify rebound hyperkalemia and treatment-related hypoglycemia. Definitive removal depends on the clinical context and may include renal excretion when feasible, a locally approved potassium binder as an adjunct, or kidney replacement therapy. [6] [7] [8]

Bicarbonate is not a default potassium-shifting intervention. In this patient with marked metabolic acidemia, its role should be discussed with senior clinicians in the context of sodium load, fluid tolerance, and the overall resuscitation plan rather than used reflexively. [6] [7] [8]

Preferred decision: Initiate the local ECG-positive hyperkalemia pathway immediately, stabilize the myocardium, begin monitored intracellular-shift therapy with a hypoglycemia-prevention plan, seek urgent renal input, and repeat ECG, potassium, and glucose at protocol-defined intervals.

Debrief: Hyponatremia is clinically important, but the ECG-positive hyperkalemia creates a more immediate arrhythmic threat. The learner should be able to separate membrane stabilization from potassium redistribution and definitive potassium removal. [6] [7]

Stage 2 — Define the sodium problem without overtrusting a diuretic-confounded urine sodium

After immediate hyperkalemia treatment, the ECG improves and potassium falls transiently to 6.1 mmol/L. Serum sodium is 119 mmol/L. Measured serum osmolality is 260 mOsm/kg, urine osmolality is 480 mOsm/kg, and urine sodium is 52 mmol/L. The patient remains oliguric. There are no seizures, coma, or focal neurological deficits.

The sodium disorder is hypotonic hyponatremia. The likely duration is unknown, which should be treated cautiously as chronic until proven otherwise. The presentation strongly suggests reduced effective circulating volume from gastrointestinal losses and acute kidney injury, with reduced kidney function and concurrent diuretic therapy complicating the interpretation of urinary sodium. A spot urine sodium alone cannot reliably assign volume status after recent loop-diuretic exposure. Serial bedside reassessment, urine output, response to carefully selected therapy, and the broader clinical context matter more than a single urine electrolyte value. [3] [5]

Because severe neurological symptoms are absent, the immediate objective is not to normalize serum sodium. The team should use frequent serum-sodium and urine-output surveillance while correcting the reversible hemodynamic insult in a way that respects the patient’s heart-failure history and current fluid tolerance. If severe symptoms emerge, a monitored 3% saline bolus protocol is used to obtain a limited initial serum-sodium rise, followed by reassessment; the goal is symptom relief, not rapid normalization. [3] [4] [5]

Decision point: Is the patient’s elevated urine sodium proof of SIADH? What information would you seek before committing to a volume-directed or antidiuretic-directed plan?

Preferred decision: Treat urine sodium as confounded by loop diuretic exposure. Reassess history, examination, serum and urine osmolality, medication timeline, renal trajectory, urine output, and response to carefully monitored treatment. Avoid routine maintenance fluid prescriptions and avoid vasopressin-antagonist therapy as an emergency rescue maneuver in an unstable, potentially hypovolemic patient.

Debrief: Correction goals and correction ceilings are not interchangeable. The exact safety ceiling depends on chronicity and risk factors; high-risk patients warrant especially conservative correction and close surveillance. [4] [5]

Stage 3 — The hidden inflection point: water diuresis and overcorrection risk

Six hours later, the patient’s perfusion has improved, urine output abruptly increases to 250 mL/hour, and serum sodium has risen from 118 to 124 mmol/L. Potassium is 5.7 mmol/L after shift therapy. The patient is more alert but remains weak.

A sudden dilute water diuresis can raise serum sodium faster than anticipated, particularly when the underlying stimulus for antidiuresis resolves. The critical response is to recognize the changing physiology promptly. Stop or revise contributors to the unintended sodium rise, intensify sodium and urine-output monitoring, and involve nephrology/critical care to consider a local rescue strategy using electrolyte-free water and/or desmopressin when correction is exceeding the patient’s safe trajectory. This is a safety intervention, not a failure of care. [3] [4] [5]

Preferred decision: Escalate monitoring immediately and use a protocolized overcorrection-rescue plan rather than allowing the serum sodium to continue rising because the patient appears clinically improved.

Debrief: A large water diuresis, not simply an excessive saline dose, is a common mechanism of overcorrection. In chronic or unknown-duration hyponatremia, biochemical improvement can coexist with emerging neurologic risk if sodium rises too fast. [4] [5]

Stage 4 — Definitive clearance and kidney replacement therapy with sodium safety in mind

Despite initial improvement, potassium rebounds to 6.4 mmol/L, bicarbonate remains low, and the patient remains oliguric with worsening azotemia. The care team is concerned that repeated redistribution therapy will not provide durable control. At the same time, routine intermittent dialysis could accelerate sodium correction if the prescription is not planned carefully.

This is an urgent multidisciplinary decision. Refractory or recurrent severe hyperkalemia with persistent acidosis and oliguria may require kidney replacement therapy. The dialysis prescription and monitoring plan must explicitly account for the concurrent hyponatremia, including the desired sodium trajectory, serial measurement, and local capability for controlled correction. [6] [7] [8]

Preferred decision: Arrange urgent renal replacement therapy with a sodium-aware prescription and continuous clinical, ECG, potassium, glucose, and serum-sodium surveillance. Avoid framing dialysis as an isolated treatment for potassium while ignoring the sodium-correction risk.

Debrief: Potassium shifting buys time; it does not eliminate total body potassium. Dialysis is a definitive removal strategy when medical management is inadequate or when associated acidosis, kidney failure, or oliguria makes durable control unlikely. [6] [7]

Stage 5 — Recovery, medication stewardship, and recurrence prevention

Over the following days, kidney function and urine output improve. Potassium normalizes, sodium is corrected cautiously without neurological deterioration, and the patient is transitioned from monitored care. Before discharge, the team reviews precipitating factors: gastrointestinal losses, reduced intake, acute kidney injury, lisinopril, spironolactone, and the patient’s limited understanding of sick-day medication management.

The acute medication holds should not become permanent by inertia. The discharge plan should specify which drugs are temporarily withheld, what laboratory and clinical criteria are needed before reintroduction, who will review the plan, and how the patient will access early outpatient testing. KDIGO emphasizes addressing contributing factors and treating hyperkalemia where possible rather than reflexively abandoning disease-modifying RAAS inhibition; however, reintroduction must be individualized after recovery of hemodynamics, kidney function, and potassium control. [1] [2]

Preferred decision: Document a time-limited medication plan, laboratory follow-up, renal and heart-failure coordination, individualized dietary counseling after non-dietary contributors are addressed, and clear return precautions for weakness, palpitations, reduced urine output, vomiting, or diarrhea. [1] [2] [7]

Expert synthesis

This case illustrates the hierarchy of acute electrolyte care. ECG-positive hyperkalemia requires immediate monitored treatment because of arrhythmic risk. Concurrent hypotonic hyponatremia must then be classified by tonicity, symptoms, chronicity, and context—not by an isolated urine sodium in a diuretic-treated patient. The trajectory of urine output is a major safety signal: recovery from antidiuresis can cause abrupt sodium overcorrection, so rescue capability must accompany treatment. Finally, renal replacement therapy can solve refractory potassium and acid-base problems but must be prescribed with the sodium trajectory in mind. Acute medication holds require a structured reassessment plan, not indefinite discontinuation by default. [1] [2] [3] [4] [5] [6] [7] [8]

Sources

Advanced Self-Assessment

Complete the 10-question Advanced self-assessment below. Detailed explanations are provided after submission.

Advanced Self-Assessment: Electrolyte Collapse in CKD

1 / 10

A 68-year-old patient with CKD G4 has potassium 6.8 mmol/L, QRS widening, and peaked T waves. He is confused and has serum sodium 118 mmol/L. Which action has the highest immediate priority?

Start fluid restriction for presumed SIADH.

Begin a chronic potassium-binder regimen and reassess tomorrow.

Initiate continuous cardiac monitoring and the institution’s ECG-positive hyperkalemia pathway.

Give a vasopressin antagonist to rapidly normalize the sodium concentration.

2 / 10

In the same patient, which statement best describes the purpose of intravenous calcium administered for hyperkalemia with ECG changes?

It removes potassium from the body through the gastrointestinal tract.

It stabilizes the cardiac membrane but does not lower the serum potassium concentration.

It reliably corrects metabolic acidosis and prevents potassium rebound.

It replaces the need for potassium-shifting therapy if the ECG improves.

3 / 10

After a local insulin–glucose protocol is given for severe hyperkalemia, which monitoring plan is most appropriate?

Check serum potassium only if weakness persists.

Obtain one repeat potassium the next morning if the ECG normalizes.

Repeat an ECG only if potassium increases on the next laboratory panel.

Perform protocolized serial potassium and glucose checks, continue cardiac monitoring, and reassess for rebound or hypoglycemia.

4 / 10

A patient with hypotonic hyponatremia received high-dose loop diuretics before arrival. Urine sodium is 52 mmol/L. Which interpretation is most appropriate?

Urine sodium alone cannot establish euvolemia or SIADH after recent loop-diuretic exposure; assess the full clinical and laboratory context.

Urine sodium above 40 mmol/L proves SIADH, so give a vasopressin antagonist immediately.

Urine sodium above 40 mmol/L excludes reduced effective circulating volume.

The urine sodium result makes urine osmolality and medication history unnecessary.

5 / 10

A patient with confirmed hypotonic hyponatremia develops a seizure. Which statement best reflects the immediate therapeutic objective?

Normalize serum sodium to 135 mmol/L during the first 24 hours.

Raise serum sodium by a fixed 8–10 mmol/L during the next 24 hours regardless of risk factors.

Avoid hypertonic saline because chronicity is uncertain.

Use the local monitored 3% saline bolus protocol to achieve a limited early rise sufficient to improve severe symptoms, then reassess and avoid unnecessary further correction.

6 / 10

Six hours after initial treatment, serum sodium has increased from 118 to 124 mmol/L and urine output abruptly rises to 250 mL/hour. The patient is more alert. What is the best next action?

Continue all current fluids unchanged because clinical status has improved.

Intensify serum-sodium and urine-output monitoring and activate a protocolized overcorrection-rescue discussion, including electrolyte-free water and/or desmopressin when indicated.

Administer a vasopressin antagonist to maintain high urine output.

Ignore the sodium trajectory unless it exceeds the laboratory reference range.

7 / 10

After emergency stabilization, a patient with CKD G4 remains on an ACE inhibitor for proteinuric kidney disease. Which longitudinal plan is best?

Review contributors to hyperkalemia, kidney function, volume status, diet, interacting medicines, and recurrence prevention before making an individualized decision about continuing or adjusting RAAS inhibition.

Permanently discontinue all RAAS inhibition after any potassium concentration above 6.0 mmol/L.

Restart every pre-admission medicine immediately once the ECG normalizes.

Use a chronic potassium binder as a substitute for medication review and follow-up testing.

8 / 10

Despite membrane stabilization and potassium-shifting treatment, the potassium concentration remains 6.6 mmol/L with recurrent ECG abnormalities in a patient with advanced CKD and oliguria. What is the best next step?

Repeat potassium-shifting therapy indefinitely without involving specialist services.

Wait until the next routine outpatient dialysis review because the patient has CKD.

Urgently involve nephrology and critical-care services to assess definitive potassium removal, including dialysis where indicated.

Stop cardiac monitoring once one ECG appears less abnormal.

9 / 10

Which diagnostic approach is most appropriate for a patient with suspected hypotonic hyponatremia and complex cardiorenal disease?

Classify tonicity, determine symptom severity and likely chronicity, review medications and volume clues, obtain urine studies with awareness of confounding, and reassess the diagnosis as new data and response to treatment emerge.

Treat every low serum sodium as SIADH until proven otherwise.

Use a single urine sodium measurement as the final test of volume status.

Delay all assessment until the sodium concentration rises into the reference range.

10 / 10

Which discharge and follow-up plan best reduces recurrent electrolyte emergencies after this admission?

Provide a generic low-potassium diet leaflet without medication review or laboratory follow-up.

Arrange medication reconciliation, individualized dietary and sick-day counseling, an early kidney-function and electrolyte recheck, and clear escalation instructions tailored to the underlying cause.

Discontinue all chronic kidney-disease therapies indefinitely and discharge without monitoring.

Delay every laboratory check until the next annual review if symptoms are absent.

Your score is

The average score is 90%

By Wordpress Quiz plugin

Supporting presentation

The slide deck is provided as a supporting learning resource after the self-assessment.

Download the Electrolyte Disorders supporting presentation (PPTX)